The in vitro synergistic and antibiofilm activity of Ceftazidime/avibactam against Achromobacter species recovered from respiratory samples of cystic fibrosis patients

被引：0
|
作者：
Emel Mataracı-Kara [1 ]
Damla Damar-Çelik [1 ]
Berna Özbek-Çelik [2 ]
机构：
[1] Istanbul University,Department of Pharmaceutical Microbiology, Faculty of Pharmacy
[2] Marmara University,Department of Pharmaceutical Microbiology, Faculty of Pharmacy
来源：
European Journal of Clinical Microbiology & Infectious Diseases | 2025年 / 44卷 / 3期
关键词：
Ceftazidime/avibactam; Synergy; spp.; Bactericidal activity; Antibiofilm activity;
D O I：
10.1007/s10096-024-05017-0
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：587 / 596
页数：9
相关论文
共 50 条
  • [1] Trends in ceftazidime-avibactam activity against multidrug-resistant organisms recovered from respiratory samples of cystic fibrosis patients
    Farfour, Eric
    Trochu, Erwan
    Devin, Clotilde
    Martin, Emilie Cardot
    Limousin, Lucie
    Roux, Antoine
    Picard, Clement
    Jolly, Emilie
    Vasse, Marc
    Lesprit, Philippe
    TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (05)
  • [2] Diversity of Achromobacter species recovered from patients with cystic fibrosis, in Argentina
    Papalia, Mariana
    Steffanowski, Carla
    Traglia, German
    Almuzara, Marisa
    Martina, Pablo
    Galanternik, Laura
    Vay, Carlos
    Gutkind, Gabriel
    Soledad Ramirez, Maria
    Radice, Marcela
    REVISTA ARGENTINA DE MICROBIOLOGIA, 2020, 52 (01): : 13 - 18
  • [3] In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis
    Nolan, Patrick J.
    Jain, Raksha
    Cohen, Leah
    Finklea, James D.
    Smith, Tiffeny T.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2021, 99 (02)
  • [4] Antimicrobial activity of ceftazidime/avibactam, ceftolozane/tazobactam and comparator agents against Pseudomonas aeruginosa from cystic fibrosis patients
    Sader, Helio S.
    Duncan, Leonard R.
    Doyle, Timothy B.
    Castanheira, Mariana
    JAC-ANTIMICROBIAL RESISTANCE, 2021, 3 (03):
  • [5] In vitro activity of minocycline against respiratory pathogens from patients with cystic fibrosis
    Kurlandsky, LE
    Fader, RC
    PEDIATRIC PULMONOLOGY, 2000, 29 (03) : 210 - 212
  • [6] In vitro activity of β-lactams in combination with avibactam against multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Achromobacter xylosoxidans isolates from patients with cystic fibrosis
    Mathy, Vincent
    Grohs, Patrick
    Compain, Fabrice
    JOURNAL OF MEDICAL MICROBIOLOGY, 2018, 67 (09) : 1217 - 1220
  • [7] Avibactam confers susceptibility to a large proportion of ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients
    Chalhoub, Hussein
    Tunney, Michael
    Elborn, J. Stuart
    Vergison, Anne
    Denis, Olivier
    Plesiat, Patrick
    Kahl, Barbara C.
    Van Bambeke, Francoise
    Tulkens, Paul M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (05) : 1596 - 1598
  • [8] In vitro activity of meropenem, imipenem, cefepime and ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Christenson, JC
    Korgenski, EK
    Daly, JA
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (06) : 899 - 901
  • [9] In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Manduru, M
    Mihm, LB
    White, RL
    Friedrich, LV
    Flume, PA
    Bosso, JA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) : 2053 - 2056
  • [10] In vitro activity of ceftazidime/avibactam against ceftazidime-resistant Enterobacterales and Pseudomonas aeruginosa from hospitalised patients in Germany
    Kresken, Michael
    Korte-Berwanger, Miriam
    Pfennigwerth, Niels
    Gatermann, Soren G.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 25 : 337 - 338
12345